Your trusted source for evidence-based medical information, reviewed by healthcare professionals
Description RYDAPT is a kinase inhibitor used to treat specific adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 mutation-positive, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation. It is also indicated for the treatment of aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast … Read more
Mekinist (Trametinib) by Novartis Pharmaceuticals Corporation Indications and Usage Mekinist is a kinase inhibitor used for the treatment of various conditions: Melanoma with BRAF V600E or V600K mutations Unresectable or metastatic melanoma Metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation Locally advanced or metastatic anaplastic thyroid cancer (ATC) with BRAF V600E mutation Unresectable … Read more